It wasn't the C-Suites types who made Celgene special son. They were as corrupt and incompetent as any around.Left a couple of your Legends in C-Suite. Please come pick them up.
...and the stock trades in the $40's/share. Maybe Celgenies should stop running in circles?
In R&D maybe 4 are very good/great scientists and Directors. BMS recently slagged a few VP's from both sides, (had it coming). Celgene's 'original contributions and innovations now derivative of existing legacy/art/matter, [or are purchased) with Celgene scientists, (from the beginning), arriving very inexperienced and having no boots for a large organization. Many bench level and above, left from both sides in the ensuing chaos with the best BMS scientists (those with remaining career mileage), leaving very early on following the acquisition. It's really a shit show now.It wasn't the C-Suites types who made Celgene special son. They were as corrupt and incompetent as any around.
What made Celgene special was the GMs of the divisions - they build a culture of performance and paid people to perform. I'm talking GMs, VPs and Directors.
I left. I am happy with that decision.In R&D maybe 4 are very good/great scientists and Directors. BMS recently slagged a few VP's from both sides, (had it coming). Celgene's 'original contributions and innovations now derivative of existing legacy/art/matter, [or are purchased) with Celgene scientists, (from the beginning), arriving very inexperienced and having no boots for a large organization. Many bench level and above, left from both sides in the ensuing chaos with the best BMS scientists (those with remaining career mileage), leaving very early on following the acquisition. It's really a shit show now.
NE HEM is great despite BMS people, not because of them.
Yes!Left a couple of your Legends in C-Suite. Please come pick them up.
We will rise!In R&D maybe 4 are very good/great scientists and Directors. BMS recently slagged a few VP's from both sides, (had it coming). Celgene's 'original contributions and innovations now derivative of existing legacy/art/matter, [or are purchased) with Celgene scientists, (from the beginning), arriving very inexperienced and having no boots for a large organization. Many bench level and above, left from both sides in the ensuing chaos with the best BMS scientists (those with remaining career mileage), leaving very early on following the acquisition. It's really a shit show now.
Son? Meet me at the President's Links in NYC. Try to get in...It wasn't the C-Suites types who made Celgene special son.
In R&D maybe 4 are very good/great scientists and Directors. BMS recently slagged a few VP's from both sides, (had it coming). Celgene's 'original contributions and innovations now derivative of existing legacy/art/matter, [or are purchased) with Celgene scientists, (from the beginning), arriving very inexperienced and having no boots for a large organization. Many bench level and above, left from both sides in the ensuing chaos with the best BMS scientists (those with remaining career mileage), leaving very early on following the acquisition. It's really a shit show now.
Phil Asheeo and Anya Niese are still aroundname the good ones left!
Son? Meet me at the President's Links in NYC. Try to get in...
Son
In the meantime get some of that Celgene attitude to work and get BMS SP out of the toilet...you know, like the other PhRMA listings...
...Son
Wrong company...some people on this board have an interest, but do not work at BMS...not a fan of 62nd, not east nor west
I spend Thursdays at the Met Club. Come on down anytime you want. You'll recognize me right away and I'll tune that cuck PPK ass right up.
Then come on down son, and I'll give you the business. I won't even bother with foreplay.Wrong company...some people on this board have an interest, but do not work at BMS...
Son
...and falling since the Celgene acquisition.Market Cap down to 87 billion
While you two are jerking each other off at your NYC clubs I'll be in So FL doing trains on your girlfriends and sending you videos.
A feature was Celgene R&D 'Leadership' stripping BMS talent of agency. They really made toxic decisions, then thought everyone would just fall in line. We just walked away.the best thing that the old CEO did was put Kate in charge of GDO. Led to such a horrid work environment that we all left for greener pastures. Life has never been better at other places. What has happened is that the talent left and only the deadwood stayed. So sad to see what has happened to this lovely organization. However, what can you expect when clinical development for everything but oncology was pushed to PRA. They thought PRA would do it better than leading the research in house. so we took our skills somewhere and made the other places be better!
In just a matter of only a few years Giovanni's scientific leadership choices tarnished BMS' scientific reputation across the industry so very badly that most think of it as taking generations to recover. In my opinion, and for many others, from vision to strategy to execution, what a catastrophe.A feature was Celgene R&D 'Leadership' stripping BMS talent of agency. They really made toxic decisions, then thought everyone would just fall in line. We just walked away.
